SCHEMBL1534422

SCHEMBL1534422

COc1ccc2c(=O)c(I)c(-c3ccccc3)oc2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.45
ADORA1 P30542 1/20 0.45
ABCG2 Q9UNQ0 7/20 0.42
ABCC1 P33527 2/20 0.42
CYP1A1 P04798 3/20 0.41
CYP1B1 Q16678 3/20 0.41
CYP1A2 P05177 3/20 0.41
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
ALDH1A1 P00352 5/20 0.40
KDM4E B2RXH2 4/20 0.40
MAPT P10636 4/20 0.40
CYP3A4 P08684 3/20 0.40
HPGD P15428 3/20 0.40
HSD17B10 Q99714 3/20 0.40
MEN1 O00255 1/20 0.40
THRB P10828 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP2C9 P11712 3/20 0.38
CYP2C19 P33261 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1534473 0.81 KDM4E (0.43) ADORA2AADORA1ABCG2ABCC1CYP1A1
SCHEMBL13500432 0.77 KDR (0.39) ABCG2ABCC1ALDH1A1KDM4EMAPT
SCHEMBL1534584 0.73 KDM4E (0.54) ADORA2AADORA1ABCG2CYP1A1CYP1B1
SCHEMBL1534826 0.73 AKT1 (0.47)
SCHEMBL1534565 0.72 ALDH1A1 (0.74) ABCG2CYP1A2ALDH1A1KDM4EMAPT
SCHEMBL18864500 0.72 KDM4E (0.47) ABCG2CYP1A1CYP1B1CYP1A2ALDH1A1
SCHEMBL1534599 0.71 ABCG2 (0.54) ABCG2ABCC1CYP1A1CYP1B1CYP1A2
SCHEMBL1534410 0.71 MAOA (0.58) ABCG2ABCC1CYP1A1CYP1B1CYP1A2
SCHEMBL1534501 0.70 MAOA (0.57) ABCG2ABCC1CYP1A1CYP1B1CYP1A2
SCHEMBL1534460 0.70 MEN1 (0.58) ABCG2CYP1A1CYP1B1CYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546376-B2 Pharmaceutical compounds ALMAC DISCOVERY LIMITED (GB) 2013-10-01 US disclosed
US-20120238541-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2012-09-20 US disclosed
EP-2473495-A1 PHARMACEUTICAL COMPOUNDS Almac Discovery Limited (GB) 2012-07-11 EP disclosed
WO-2011033265-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2011-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120238541-A1 PHARMACEUTICAL COMPOUNDS PIK3CA, PLK1, MTOR ADORA2A 2210/4885ADORA1 2853/4885ABCG2 507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.